TSE:BHC Bausch Health Companies (BHC) Stock Price, News & Analysis C$7.72 +0.17 (+2.25%) As of 04:00 PM Eastern Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesBuy This Stock About Bausch Health Companies Stock (TSE:BHC) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get BHC alerts:Sign Up Key Stats Today's RangeC$7.54▼C$7.7250-Day RangeC$6.82▼C$8.0952-Week RangeC$6.06▼C$11.97Volume110,218 shsAverage Volume459,404 shsMarket CapitalizationC$2.88 billionP/E RatioN/ADividend Yield0.76%Price TargetN/AConsensus RatingHold Company Overview Bausch Health Companies Inc. is a global company that develops manufactures and markets a range of pharmaceutical medical device and over-the-counter products primarily in the therapeutic areas of eye health gastroenterology and dermatology. We are delivering on our commitments as we build an innovative company dedicated to advancing global health. Our approximately 22000 employees are united around our mission of improving peoples lives with our health care products and we manufacture and market health care products directly or indirectly in approximately 100 countries. Five pillars or guiding principles represent the foundation on which we are realizing our mission as an organization: People Quality Health Care Outcomes Customer Focus Innovation and Efficiency. Read More Bausch Health Companies Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks15th Percentile Overall ScoreBHC MarketRank™: Bausch Health Companies scored higher than 15% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion1.0 / 5Analyst RatingHold Consensus RatingBausch Health Companies has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on no strong buy ratings, no buy ratings, 2 hold ratings, and no sell ratings.Amount of Analyst CoverageBausch Health Companies has received no research coverage in the past 90 days.Read more about Bausch Health Companies' stock forecast and price target. Earnings and Valuation1.3 / 5Proj. Earnings GrowthN/A Price to Earnings Ratio vs. the MarketThe P/E ratio of Bausch Health Companies is -2.38, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Bausch Health Companies is -2.38, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Growth RatioBausch Health Companies has a PEG Ratio of 0.21. PEG Ratios below 1 indicate that a company could be undervalued. Short InterestN/AShort Interest LevelN/A Short InterestThere is no current short interest data available for BHC. Dividend0.0 / 5Dividend StrengthWeak Dividend YieldBausch Health Companies has a dividend yield of 0.76%, which is in the bottom 25% of all stocks that pay dividends.Dividend GrowthBausch Health Companies does not have a long track record of dividend growth.Read more about Bausch Health Companies' dividend. News and Social Media2.3 / 5News Sentiment-0.25 News SentimentBausch Health Companies has a news sentiment score of -0.25. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.47 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 12 news articles for Bausch Health Companies this week, compared to 2 articles on an average week.Search Interest14 people have searched for BHC on MarketBeat in the last 30 days. This is an increase of 180% compared to the previous 30 days.MarketBeat Follows1 people have added Bausch Health Companies to their MarketBeat watchlist in the last 30 days. Company Ownership0.5 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, Bausch Health Companies insiders have not sold or bought any company stock.Percentage Held by Insiders11.28% of the stock of Bausch Health Companies is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by Institutions10.03% of the stock of Bausch Health Companies is held by institutions.Read more about Bausch Health Companies' insider trading history. Receive BHC Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Bausch Health Companies and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. BHC Stock News HeadlinesBausch Health Companies Inc.: Bausch Health Announces 2026 Annual Meeting of Shareholder ResultsMay 20, 2026 | finanznachrichten.deAnalysts Offer Insights on Healthcare Companies: Bausch Health Companies (BHC), Irhythm Technologies (IRTC) and Bicycle Therapeutics (BCYC)May 2, 2026 | theglobeandmail.comTicker Revealed: Pre-IPO Access to "Next Elon Musk" CompanyWe’ve found The Next Elon Musk… and what we believe to be the next Tesla. It’s already racked up $26 billion in government contracts. Peter Thiel just bet $1 Billion on it.May 25 at 1:00 AM | Banyan Hill Publishing (Ad)Analysts Have Conflicting Sentiments on These Healthcare Companies: Teladoc (TDOC), Bausch Health Companies (BHC) and AbbVie (ABBV)May 1, 2026 | theglobeandmail.comBausch Health Companies Inc. (BHC) stock rises on Q1 2026 EarningsApril 29, 2026 | quiverquant.comQWhat makes Bausch Health (BHC) appear so attractiveMarch 31, 2026 | msn.comSeparation Overhang Continues to Weigh on Bausch Health Companies Inc. (BHC) OutlookFebruary 23, 2026 | insidermonkey.comBausch Health Weighs China Aesthetics Push Against ARESTIN Milestone And DebtFebruary 22, 2026 | finance.yahoo.comSee More Headlines BHC Stock Analysis - Frequently Asked Questions How have BHC shares performed this year? Bausch Health Companies' stock was trading at C$9.53 at the start of the year. Since then, BHC stock has decreased by 19.0% and is now trading at C$7.72. How were Bausch Health Companies' earnings last quarter? Bausch Health Companies Inc. (TSE:BHC) announced its quarterly earnings data on Wednesday, April, 29th. The company reported $1.08 earnings per share (EPS) for the quarter. The business had revenue of $3.51 billion for the quarter. Bausch Health Companies had a negative net margin of 13.54% and a positive trailing twelve-month return on equity of 120.43%. How do I buy shares of Bausch Health Companies? Shares of BHC stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers. What other stocks do shareholders of Bausch Health Companies own? Based on aggregate information from My MarketBeat watchlists, some other companies that Bausch Health Companies investors own include Chesapeake Energy (CHKAQ), Meta Platforms (META), Advanced Micro Devices (AMD), Enbridge (ENB), Shopify (SHOP), NVIDIA (NVDA) and Ford Motor (F). Company Calendar Last Earnings4/29/2026Today5/25/2026Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeTSE SectorMedical Industry Drug Manufacturers - Specialty & Generic Sub-IndustryPharmaceutical Products Current SymbolTSE:BHC CIKN/A Webwww.valeant.com Phone514-744-6792FaxN/AEmployees19,900Year FoundedN/AProfitability EPS (Trailing Twelve Months)C($3.24) Trailing P/E RatioN/A Forward P/E Ratio1.39 P/E Growth0.21Net Income-C$125.65 million Net Margins-13.54% Pretax MarginN/A Return on Equity120.43% Return on Assets4.16% Debt Debt-to-Equity Ratio-1,009.96 Current Ratio1.32 Quick Ratio0.58 Sales & Book Value Annual SalesC$10.53 billion Price / Sales0.27 Cash FlowC$1.00 per share Price / Cash Flow7.76 Book ValueC($2.92) per share Price / Book-2.64Miscellaneous Outstanding Shares373,476,000Free FloatN/AMarket CapC$2.88 billion OptionableNot Optionable Beta0.63 Analysts Agree—These Gold Picks Outshine the RestUnlock the timeless value of gold with our exclusive 2026 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.Get This Free Report This page (TSE:BHC) was last updated on 5/25/2026 by MarketBeat.com Staff. From Our PartnersSpaceX eyes a 1.75 trillion valuation - here's what to knowElon Musk's team has quietly filed confidential paperwork with the SEC for what Bloomberg estimates could be a...Brownstone Research | Sponsored$30 stock to buy before Starlink goes public (WATCH NOW!)In the next 3 minutes… James Altucher – legendary investor and venture capitalist… And someone who’s kno...Paradigm Press | SponsoredYour book attachedBill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time throug...Profits Run | SponsoredMy feud with Zohran MamdaniEmmy-winning analyst releases his next big story Whitney Tilson shocked the nation on 60 Minutes when he ac...Stansberry Research | SponsoredSpaceX IPO hides a much bigger storyThe SpaceX IPO could be the biggest in history at $1.75 trillion - but the real story isn't the IPO itself. ...Weiss Ratings | SponsoredSpaceX will mint billionaires. You won't be one of them.By the time a company goes public, 95% of profits have already been made. Insiders bought SpaceX at $20 billio...Behind the Markets | SponsoredSatellite Images Spot Potential $10 Trillion Discovery'Dark Energy': Elon Musk's Next Potential $10 Trillion Move A highly secure site in West Texas now houses a...Altimetry | SponsoredHey, it's Jon Najarian. The SpaceX IPO is right around the corner. But I discovered Elon may have something BIGGER planned. Check this out before June 9th...After being invited to the SpaceX launch headquarters in Cape Canaveral from one of Elon's top lobbyists… Hall...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Bausch Health Companies Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Bausch Health Companies With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
